Linden Thomas Advisory Services LLC Grows Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

Linden Thomas Advisory Services LLC increased its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,607 shares of the biopharmaceutical company’s stock after purchasing an additional 136 shares […]

Related Keywords

United States ,American ,Bonniel Bassler ,Arthurf Ryan , ,Regeneron Pharmaceuticals Inc ,York Mellon Corp ,Linden Thomas Advisory Services ,Exchange Commission ,News Ratings For Regeneron Pharmaceuticals Daily ,Cantor Fitzgerald ,Northern Trust Corp ,Regeneron Pharmaceuticals ,Securities Exchange Commission ,Regeneron Pharmaceuticals Company Profile ,Morgan Stanley ,American Century Companies Inc ,Nasdaq ,Regeneron Pharmaceuticals Stock Performance ,Quarter For Regeneron Pharmaceuticals ,Free Report ,Thomas Advisory Services ,Trust Corp ,New York Mellon Corp ,American Century Companies ,Century Companies ,Get Free Report ,Director Bonnie ,Director Arthur ,Visit Holdingschannel ,Regeneron Pharmaceuticals Daily ,Nasdaq Regn ,Regn ,Medical ,75886f10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,